(S)-Pyrrolidine-2-carboxylic acid, sodium salt
97%
- Product Code: 236489
CAS:
15383-56-9
Molecular Weight: | 137.11 g./mol | Molecular Formula: | C₅H₈NNaO₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD23699510 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry, light-proof |
Product Description:
Used in pharmaceutical synthesis as a chiral building block for developing active pharmaceutical ingredients, particularly in the production of antiviral and antidiabetic drugs. Its stereochemistry makes it valuable for creating enantioselective compounds. Also employed in research for peptide mimetics and enzyme inhibitors due to its structural similarity to natural amino acids. Serves as an intermediate in asymmetric synthesis where sodium salt form enhances solubility and reactivity in aqueous reaction systems.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1g | 10-20 days | $48.75 |
+
-
|
5g | 10-20 days | $184.95 |
+
-
|
25g | 10-20 days | $729.20 |
+
-
|
(S)-Pyrrolidine-2-carboxylic acid, sodium salt
Used in pharmaceutical synthesis as a chiral building block for developing active pharmaceutical ingredients, particularly in the production of antiviral and antidiabetic drugs. Its stereochemistry makes it valuable for creating enantioselective compounds. Also employed in research for peptide mimetics and enzyme inhibitors due to its structural similarity to natural amino acids. Serves as an intermediate in asymmetric synthesis where sodium salt form enhances solubility and reactivity in aqueous reaction systems.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :